|
Kenth Bergström Chairman |
BSc, Umeå University, is member of several company boards e.g. the board of Uminova Invest AB, Uminova Innovation AB and chairman of Umeå Biotech Incubator AB (UBI). Kenth Bergström has some 20 years experience from the industry, e.g. as Vice President of GE Healthcare and Amersham Biosciences, respectively, and experience from the market organisation of companies e.g. Pharmacia and ABB. |
|
Torbjörn Bäckström Principle Founder |
MD, PhD, co-founder and CEO of Umecrine AB, is currently professor at the Department of Clinical Science, Obstetrics and Gynecology, Umeå University. He is also head of the Umeå Neurosteroid Research Center. Professor Bäckström's main focus of research since 1972 is the effect of sex and stress hormones on the brain and conditions induced by these hormones, he has more than 400 scientific publications within this area and he is a frequently invited key-note speaker at scientific meetings around the world. |
|
Ola Flink |
Pharmacist, and Investment Manager at Karolinska Development AB, has more than 30 years of experience from different positions within development in the pharmaceutical industry, e.g. AstraZeneca, Apoteksbolaget, ACO and Kabi. Other board assignments include Axelar, Biosergen, Calabar and Oncopeptides. |
|
Gösta Jonsson |
MD, PhD, associate professor in histology and transmitter physiology from Karolinska Institutet, has in addition some 20 years of experience from different positions within the pharmaceutical industry as Vice President R&D Pharmacia Ophthalmics, President of Astra Arcus (CNS research) and Vice President Global Discovery Affairs, AstraZeneca. |
|
Ragnar Linder |
MSc in Chemical Engineering, has 25 years experience from different positions within Marketing & Sales and Business Development in the pharmaceutical industry e.g. as General Manager of Amgen Nordic AB, Director International Marketing of Aventis/Hoechst Marion Roussel, and Head of Marketing & Sales of Hoechst Pharmaceuticals AB. |